Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preliminary results given for TH-302 with bevacizumab in glioblastoma

Oct. 11, 2012

Zalypsis ineffective in urothelial carcinoma

Oct. 11, 2012

Phase I and II data presented for semaglutide

Oct. 11, 2012

Potential predictor of sunitinib response in renal cell carcinoma identified

Oct. 10, 2012

Favorable in vitro data reported for beta-lactamase inhibitor RPX-7009

Oct. 10, 2012

Evolva synthesizes novel topoisomerase inhibitors

Oct. 9, 2012

Combination studies of biapenem and RPX-7009 reported

Oct. 9, 2012

DVS-603 improves psoriasis symptoms

Oct. 8, 2012

Preclinical profile of the prostate cancer vaccine candidate AEZS-120

Oct. 8, 2012

Mirabegron safe in male patients with bladder outlet obstruction

Oct. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026